Overview

Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

Status:
Unknown status

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the efficacy and safety in the use of everolimus, with its onset after 3 months of treatment with calcineurin inhibitor.

Phase:

Phase 4

Details

Lead Sponsor:

Deise de Boni Monteiro de Carvalho

Treatments:

Calcineurin Inhibitors
Cyclosporine
Cyclosporins
Everolimus
Sirolimus
Tacrolimus